Mexican patients with HIV have a high prevalence of vertebral fractures.

about

Mexican patients with HIV have a high prevalence of vertebral fractures.

Item

http://www.wikidata.org/entity/Q54222374

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Mexican patients with HIV have a high prevalence of vertebral fractures.

@en

Mexican patients with HIV have a high prevalence of vertebral fractures.

@nl

type

Item

label

Mexican patients with HIV have a high prevalence of vertebral fractures.

@en

Mexican patients with HIV have a high prevalence of vertebral fractures.

@nl

prefLabel

Mexican patients with HIV have a high prevalence of vertebral fractures.

@en

Mexican patients with HIV have a high prevalence of vertebral fractures.

@nl

P1476

Mexican patients with HIV have a high prevalence of vertebral fractures

@en

P2093

Alberto Chaparro-Sánchez

http://www.w3.org/2001/XMLSchema#string

Ana Gil-Avila

http://www.w3.org/2001/XMLSchema#string

Carla I Arroyo-Anduiza

http://www.w3.org/2001/XMLSchema#string

Jesús Gaytán-Martínez

http://www.w3.org/2001/XMLSchema#string

María de Los Ángeles Berrospe-Silva

http://www.w3.org/2001/XMLSchema#string

P2860

Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine

Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.

Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.

Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.

Bone disease in HIV infection: a practical review and recommendations for HIV care providers.

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

Recommendations for evaluation and management of bone disease in HIV.

Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients.

Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection

Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.

P304

7409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4081/IDR.2018.7409

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

José Antonio Mata-Marín

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29721240

http://www.w3.org/2001/XMLSchema#string

P932

5907732

http://www.w3.org/2001/XMLSchema#string